8-Hydroxy-2’-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer

For early detection of malignant tumors, serum levels of 8-hydroxy-2’-deoxyguanosine were determined in 50 women with benign breast tumors, 50 women with breast cancer (BC), and 50 healthy women as a control group. 8-hydroxy-2’-deoxyguanosine levels were significantly increased in the BC group compared with the benign tumor and the healthy control groups; thus it can be used as a potential noninvasive biomarker for early detection of BC.